---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-047605"
form_type: "8-K"
ticker: "EMED"
cik: "0001715819"
company_name: "Electromedical Technologies, Inc"
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:37:00.566396+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ElectroMedical reports use-of-proceeds from property sale; $650K on Wellness Pro Plus

## Summary
- Net proceeds from March real estate sale: $1,358,710.56 (purchase price $2,000,000).
- Spent $290k on R&D, $150k on testing/tooling, $210k on inventory for the Wellness Pro Plus Infinity product.
- Total $650k deployed on product development; remaining proceeds not disclosed.

## SEC filing metadata
- accession: 0001104659-23-047605
- form_type: 8-K
- ticker: EMED
- cik: 0001715819
- company_name: Electromedical Technologies, Inc
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1715819/000110465923047605/0001104659-23-047605-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1715819/000110465923047605/tm2313341d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-047605
- JSON: https://secwatch.observer/filing/0001104659-23-047605.json
- Plain text: https://secwatch.observer/filing/0001104659-23-047605.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.